Rein 3D PRINT MECHANICS
Multimodal Imaging of the Biomechanical Properties of Kidney Tumors: Feasibility, Inter-modality Correspondence and Diagnostic Value
University Hospital, Bordeaux
50 participants
Mar 7, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this innovative project is to evaluate the correspondence between several imaging modalities for characterizing the elasticity of healthy and pathological renal tissue which could help improve the realism of 3D prints used by urological surgeons and allow the identification of new, complementary imaging biomarkers. The main objective is to develop a predictive model of the biomechanical properties of normal and pathological kidney tissue, as assessed by the reference method (Magnetic Resonance (MR)-elastography).
Eligibility
Inclusion Criteria6
- Adult patients (≥ 18 years of age)
- Scheduled for surgical management with nephrectomy for kidney tumor in the urology department of Bordeaux University Hospital
- CT scan available or scheduled for surgery
- Consent expressed for integration of the UroCCR database
- Expressed consent for participation in the Rein 3D Print Mechanics study
- Patients affiliated or benefiting from social security system
Exclusion Criteria11
- \- Pregnant or breast-feeding women
- Contraindication to MRI (Magnetic Resonance Imaging)
- Contraindication to injection of gadoline contrast agents
- Biopsy prior to MRI, CT and ultrasound scans (risk of artifactual alteration, via iatrogenic hemorrhagic changes, of the biomechanical properties of the renal tumor and parenchyma).
- Presence of thoracolumbar arthrodesis material
- Obese patient (body mass index ≥ 30 kg/m²)
- Cystic renal tumors with solid component (corresponding to either parietal thickening or tumor bud) \< 2 cm
- Necrotic renal tumors with solid component (corresponding to either parietal thickening or tumor bud) \< 2 cm
- Ascites
- Person under legal protection
- Difficulty understanding and expressing in French
Interventions
Imaging acquisition
Imaging acquisition
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06525831